Search Results
Search results for "fluorescent ligands"
Results found for "fluorescent ligands"
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
epidermal growth factor-induced phosphorylation of Gαi at specific residues predominantly inhibits ligand-induced Key findings include: Phosphorylation Hotspots: P Loop (Ser44, Ser47, Thr48): Impairs ligand-stimulated Interdomain Cleft (Ser151, Tyr154, Tyr155): Phosphorylation at Tyr154 and Tyr155 impaired ligand-stimulated C Terminus (Tyr320): Phosphorylation at Tyr320 disrupted GÎČγ binding, receptor coupling, and ligand-stimulated
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
De Graaf for their excellent work on Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability Molecular Insights into GPCR Function Comparative Study of Allosteric GPCR Binding Sites and Their Ligandability
- GPCR Happy Hour â Boston, Sept 2025
The most valuable conversations donât happen under fluorescent lights â they happen when the ties are
- đ° GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
5 to 26, 2024 What Youâll Learn during the four sessions: How to measure pharmacologic activity of ligands (affinity, efficacy, co-operativity) Determining mechanisms of action for new GPCR ligands Key elements 31, 2024 What Youâll Master during the five sessions: Utilizing new cellular assays to analyze GPCR ligand behavior Predicting activity and in vivo target coverage with real-time kinetics Discovering new ligands
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
A diverse pharmacopoeia of cannabinoid ligands is available, which has led to considerable advancements However, until recently, most CB2 ligands were highly lipophilic and as such not optimal for clinical A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties We review the current state of CB2 ligand development and progress in optimising physicochemical properties
- A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
protein-coupled receptors are a useful addition to the molecular pharmacology assay toolbox to characterize ligand agonism and inverse agonism on living cells in a microplate reader assay format upon stimulation with H3R ligands have further characterized this H3R biosensor on intact cells by monitoring the effect of consecutive ligand injections in time and evaluating its compatibility with photopharmacological ligands that contain a ready-to-use, high-throughput alternative for radioligand binding assays that in addition can also detect ligand
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
Among the challenging GPCRs are approximately 50 that have large natural ligands. The significantly increased surface area of ligand-receptor interface for these GPCRs makes modulation These approaches include generating ligand analogs by precision engineering the natural small protein ligand of the receptor. Small protein GPCRs feature a two-component binding mechanism in which one part of the ligand engages
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
A diverse pharmacopeia of cannabinoid ligands is available, which has led to considerable advancements However, until recently, most CB2 ligands were highly lipophilic and as such, not optimal for clinical A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties We review the current state of CB2 ligand development and progress in optimizing physicochemical properties
- Your GPCR Program Decisions Depend on Good Data Interpretation
CRCM Must-read publications : AlphaFold3 benchmarking for GPCRs; new structural insights into peptide ligand At first glance, when a ligand binds at two different affinities in the same system, it seems logical conditions, what appears to be a second high-affinity site may simply reflect kinetic factorsâsuch as ligand-receptor-G
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
The conversation moves beyond theory into real-world tradeoffs: fluorescence-based assays, internalization
- đ° GPCR Weekly News, October 9 to 15, 2023
the Gαi3 heterotrimers Activation/Deactivation Free-Energy Profiles for the ÎČ2-Adrenergic Receptor: Ligand ascosporogenesis in the wheat scab fungus GPCR Binders, Drugs, and more Development of Photoswitchable Tethered Ligands Meeting February 3 - 7, 2024 | SLAS2024 International Conference and Exhibition March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
Study of small molecule binding to live cells provides important information on the characterization of ligands coupled receptor (GPCR), we used one antagonist as probe and multiple other antagonists as competitor ligands Competition binding analysis by titration of five known ligands suggested a good correlation with their This versatile method allows quantitative characterization of ligand binding to cell surface expressed
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
receptor-lipid interface represent an uncharacteristic binding location that raises many questions about the ligand Although ligand-lipid interactions are weak, lipid tails play a role in ligand binding pose stability We discuss physicochemical aspects of ligand binding at the receptor-lipid interface and suggest a compound library enriched by weak donor groups for ligand search in such sites."
- Do You Believe AI Could Accelerate Drug Discovery?
However, the impact on structure-based ligand discovery remained uncertain due to the necessity for accurately found that AF2 models achieved accurate side-chain predictions and successfully docked high-affinity ligands AlphaFold2 structures guide prospective ligand discovery.
- Therapeutic validation of an orphan G proteinâcoupled receptor
Historically, ligands for GPCRs have been identified before their receptor counterparts. , several unidentified receptors have been found and were labelled as âorphanâ for their endogenous ligands Therefore, matching a ligand to an orphan GPCRs, the process of de-orphanizing, is of great importance and 2. which ligands can be used as tool compounds to study the function and biology of this receptor In addition, several GPR84 ligands have been described as well as GPR84 knockout mice.
- đ° GPCR Weekly News, December 18 to 31, 2023
Heydenreich, Michel Bouvier, Brian Kobilka, M Madan Babu, and their team's work on Molecular determinants of ligand GPCRs) Associated with Lambda-Cyhalothrin Detoxification in Cydia pomonella Molecular determinants of ligand autophagy-mediated NLRP3 degradation Methods & Updates in GPCR Research Direct Binding Methods to Measure Receptor-Ligand Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its...
conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its interactions with antagonist and agonist ligands receptor 1 (CX3CR1), a member of the class A of G Protein-Coupled Receptors (GPCR) superfamily, and its ligand characterize the conformational ensemble of the receptor in the presence of its antagonist and agonist ligands the receptor conformational changes and described interactions within its key regions and the bounded ligands
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
High-throughput screening for receptor ligands was booming, and Sokhom was at the center of it.
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
Fast-forward a few thousand years, and weâre talking beta receptors, receptor theory, and AI-generated ligands
- đ° GPCR Weekly News, May 27 to June 2, 2024
Brendan Creemer, Thomas Gardella, and Ross Cheloha for their work on Highly biased agonism for GPCR ligands GPCR Activation and Signaling Highly biased agonism for GPCR ligands via nanobody tethering Mechanistic deficits GPCRs in Cardiology, Endocrinology, and Taste The full-length TSH receptor is stabilized by TSH ligand orientation using a neurotensin receptor 1 peptide Illuminating the neuropeptide Y4 receptor and its ligand
- From Multiplex to Models: Scaling Up GPCR Discovery in the Post-Silo Era
 (e.g., 14-3-3) Heterodimerization Endogenous vs. overexpressed systems Orphan GPCR deorphanization Ligand
- Location bias contributes to functionally selective responses of biased CXCR3 agonists
November 2022 "Some G protein-coupled receptor (GPCR) ligands act as "biased agonists" that preferentially differential subcellular signaling contributes to the biased signaling generated by three endogenous ligands The signaling profile of CXCR3 changes as it traffics from the plasma membrane to endosomes in a ligand-specific
- đ° GPCR Weekly News, December 4 to 10, 2023
by a chemerin-derived agonist Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism GPCR Binders, Drugs, and more Design and structural validation of peptide-drug conjugate ligands Annual Meeting March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit March 23 - 24, 2024 | Ligand Recognition and Molecular Gating Seminar March 24 - 29, 2024 | Ligand Recognition and Molecular Gating
- Antibodies That Donât Block, They Activate: A New Angle on Autoimmunity and GPCRs
sees a future where this system is not just used for detection, but for functional screening : add ligands
- Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...
Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears exposed to the membrane lipids. experimental structures do not usually account for the surrounding lipids, and their apparent contribution to ligand
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of ”-opioid receptors
metadynamics-enhanced conformational sampling are used here to determine the different interactions of these two ligands The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes This finding reveals a dynamic mechanism for the response of MOR to different ligands and provides a basis for the discovery of new ligands for MOR at the atomic level."
- GPCR/endocytosis/ERK signaling/S2R is involved in the regulation of the internalization...
We recently have shown that fluorescently labeled Hst1 (F-Hst1) targets and activates mitochondria, presenting
- From Pipettes to Platforms: The Evolution of GPCR Research
Just her, radioactive ligands, and steady hands. could make or break the result, The pace and precision of GPCR research today â from high-throughput ligand
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
isoforms, a case for functionally Gs protein-selective GPCRs, and new methods for detecting simultaneous ligand Learn how his research aims to develop models that can distinguish between active and inactive ligands , paving the way for computational ligand discovery even where experimental data is scarce.
- GPCRs at Discovery on Target 2026
unusually wide slice of the field: Antifibrotic and anti-inflammatory targets, including GPR68 Biased ligand Terry's Corner is our room where he breaks down receptor pharmacology, functional selectivity, and ligand














